glutathione kidney damage Full article: metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis Full article: Reduced glutathione ameliorates
Description
T2DM patients: Glycemic control is recommended to slow the progression of neuropathy
Biochem Pharmacol (2009) 77(4):73445
In Supplementary Tables S4 and S5 are reported the statistically significant differences obtained by comparing the levels of e-GST and e-CAT enzymatic activities in different species
References (this section): Eli Lilly: notes GI side effects commonly reported and often during dose escalation (Phase 2 summary) NEJM (2023): safety/adverse events in Phase 2 publication Is retatrutide FDA approved
